Evidence map›Paper›PMID 31690722›Full record

ArticleNature communications2019

Metabolic dysregulation in vitamin E and carnitine shuttle energy mechanisms associate with human frailty.

Nicholas J W Rattray, Drupad K Trivedi, Yun Xu, Tarani Chandola, Caroline H Johnson, Alan D Marshall, Krisztina Mekli, Zahra Rattray, Gindo Tampubolon, Bram Vanhoutte and 5 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed, 1 pooled it
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 1 synthesis or guideline pooled it, 99 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Elevating Circulating L-Kynurenine Promotes Frailty in Aging Mice.Journal of cachexia, sarcopenia and muscle · 2026
    Article
  11. Article
  12. Article
  13. Article
  14. Biomarkers and Clinical Evaluation in the Detection of Frailty.International journal of molecular sciences · 2025
    Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 3 countries.

Nicholas J W RattraySchool of Chemistry, Manchester Institute for Biotechnology, University of Manchester, 131 Princess Street, Manchester, M1 7DN, UK. nicholas.rattray@strath.ac.uk.ORCID http://orcid.org/0000-0002-3528-6905
Drupad K TrivediSchool of Chemistry, Manchester Institute for Biotechnology, University of Manchester, 131 Princess Street, Manchester, M1 7DN, UK.
Yun XuSchool of Chemistry, Manchester Institute for Biotechnology, University of Manchester, 131 Princess Street, Manchester, M1 7DN, UK.ORCID http://orcid.org/0000-0003-3228-5111
Tarani ChandolaCathie Marsh Institute for Social Research, University of Manchester, Manchester, M13 9PT, UK.
Caroline H JohnsonDepartment of Environmental Health Sciences, Yale School of Public Health, Yale University, 60 College Street, New Haven, CT, 06520, USA.
Alan D MarshallCathie Marsh Institute for Social Research, University of Manchester, Manchester, M13 9PT, UK.
Krisztina MekliCathie Marsh Institute for Social Research, University of Manchester, Manchester, M13 9PT, UK.
Zahra RattrayStrathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, 161 Cathedral Street, Glasgow, G4 0RE, UK.ORCID http://orcid.org/0000-0002-8371-8549
Gindo TampubolonCathie Marsh Institute for Social Research, University of Manchester, Manchester, M13 9PT, UK.
Bram VanhoutteCathie Marsh Institute for Social Research, University of Manchester, Manchester, M13 9PT, UK.ORCID http://orcid.org/0000-0002-8032-9214
Iain R WhiteSchool of Chemistry, Manchester Institute for Biotechnology, University of Manchester, 131 Princess Street, Manchester, M1 7DN, UK.
Frederick C W WuFaculty of Medical and Human Sciences, Institute of Human Development, Centre for Endocrinology and Diabetes, Andrology Research Unit, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, UK.
Neil PendletonDivision of Neuroscience and Experimental Psychology, School of Biological Sciences, Manchester Academic Health Science Centre, University of Manchester Salford Royal Hospital, Manchester, M6 8HD, UK.ORCID http://orcid.org/0000-0003-0794-2386
James NazrooCathie Marsh Institute for Social Research, University of Manchester, Manchester, M13 9PT, UK.
Royston GoodacreSchool of Chemistry, Manchester Institute for Biotechnology, University of Manchester, 131 Princess Street, Manchester, M1 7DN, UK.
University of Manchester · GBUniversity of Liverpool · GBManchester Academic Health Science Centre · GBUniversity of Strathclyde · GBUniversity of Nova Gorica · SIYale University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Medical Research Council G1001375NCATS NIH HHS UL1 TR001863RCUK | Medical Research Council (MRC) 190 MRC G1001375/1
6 · The paper itself

Abstract

Global ageing poses a substantial economic burden on health and social care costs. Enabling a greater proportion of older people to stay healthy for longer is key to the future sustainability of health, social and economic policy. Frailty and associated decrease in resilience plays a central role in poor health in later life. In this study, we present a population level assessment of the metabolic phenotype associated with frailty. Analysis of serum from 1191 older individuals (aged between 56 and 84 years old) and subsequent longitudinal validation (on 786 subjects) was carried out using liquid and gas chromatography-mass spectrometry metabolomics and stratified across a frailty index designed to quantitatively summarize vulnerability. Through multivariate regression and network modelling and mROC modeling we identified 12 significant metabolites (including three tocotrienols and six carnitines) that differentiate frail and non-frail phenotypes. Our study provides evidence that the dysregulation of carnitine shuttle and vitamin E pathways play a role in the risk of frailty.

Indexed as

Energy MetabolismAgedAgingCarnitineConfounding Factors, EpidemiologicDiscriminant AnalysisFemaleFrailtyHumansMaleMetabolic Networks and PathwaysMiddle AgedPhenotypePrincipal Component AnalysisReproducibility of ResultsVitamin ECarnitineVitamin E

Identifiers

PMID31690722
PMCPMC6831565
OpenAlexW2987425466

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.